Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 9 citing articles:

The cenobamate KORK study—A prospective monocenter observational study investigating cenobamate as an adjunctive therapy in refractory epilepsy, with comparisons to historical cohorts treated with add‐on lacosamide, perampanel, and brivaracetam
Bernhard J. Steinhoff, Dimitra Georgiou, Tassanai Intravooth
Epilepsia Open (2024) Vol. 9, Iss. 4, pp. 1502-1514
Open Access | Times Cited: 10
Post-marketing Experience with Cenobamate in the Treatment of Focal Epilepsies: A Multicentre Cohort Study
Adam Strzelczyk, Felix von Podewils, Hajo M. Hamer, et al.
CNS Drugs (2025)
Open Access | Times Cited: 1
Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy
Laurent M. Willems, Milena van der Goten, Felix von Podewils, et al.
CNS Drugs (2023) Vol. 37, Iss. 6, pp. 531-544
Open Access | Times Cited: 19
A Phase 4, multicenter, prospective, non-interventional, observational study to investigate the effectiveness and safety/tolerability of perampanel when used as first adjunctive therapy in routine clinical practice in people with epilepsy: Study 512
С. Г. Бурд, Giovanni Assenza, Sofia Quintas, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Efficacy and safety of perampanel in genetic generalized epilepsy: a retrospective, single-center study in China
Hua Li, Peiqi Zhang, Xiaoli Dong, et al.
Epilepsy Research (2025), pp. 107591-107591
Closed Access
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study
Angelo Pascarella, Lucia Manzo, Sara Gasparini, et al.
Journal of the Neurological Sciences (2024) Vol. 462, pp. 123106-123106
Closed Access | Times Cited: 3
Long-term efficacy and safety of perampanel as an add-on therapy in patients with epilepsy
Yukika Arai, Motoki Inaji, K. Shimizu, et al.
Epilepsy Research (2024) Vol. 200, pp. 107307-107307
Closed Access | Times Cited: 2
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study
Angelo Pascarella, Sara Gasparini, Lucia Manzo, et al.
Journal of the Neurological Sciences (2023) Vol. 455, pp. 122797-122797
Open Access | Times Cited: 4
Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review
Seungyoun Moon, Lance Watkins, Máire O’Dwyer, et al.
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 11, pp. 1097-1105
Closed Access | Times Cited: 1
Efficacy and safety of perampanel as early add-on therapy in Chinese patients with focal-onset seizures: a multicenter, open-label, single-arm study
Lehong Gao, Qiang Lu, Zan Wang, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 2
Page 1

Scroll to top